CoChat

The association between hyperglycaemia on admission and 180‐day mortality in acute myocardial infarction patients with and without diabetes

Ainla, T., Baburin, A., Teesalu, R., Rahu, M. · 2005 · Diabetic Medicine
Cited by 75

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Aim To evaluate the association between hyperglycaemia on admission, previously known diabetes and 180‐day mortality in acute myocardial infarction (AMI) patients. Methods The study population consisted of 779 consecutive AMI patients from the Myocardial Infarction Registry in Estonia who had an admission venous plasma glucose level recorded and who were admitted to the Tartu University Clinics within a period of 2 years. Logistic regression analysis was used to estimate crude and adjusted odds ratios (OR) with 95% confidence interval (95% CI). Results In patients without a history of diabetes, glucose level was ≤ 11.0 mmol/l in 556 patients (group 1) and > 11.0 mmol/l in 109 patients (group 2). Of those with diabetes, glucose level was ≤ 11.0 mmol/l in 30 patients (group 3) and > 11.0 mmol/l in 84 patients (group 4). Non‐diabetic hyperglycaemic patients underwent more resuscitations outside of hospital (group 2, 31.2% vs. group 1, 2.0% vs. group 3, 6.7% vs. group 4, 6.0%, P < 0.0001) and had a higher 180‐day mortality compared with other groups (group 2, 47.7% vs. group 1, 14.1% vs. group 3, 26. 7% vs. group 4, 29.8%, P < 0.0001). After adjustment for potentially confounding factors, hyperglycaemic non‐diabetic (OR 4.35, 95% CI 1.79–10.59), but not diabetic (OR 1.79, 95% CI 0.62–5.15) status, remained an independent predictor of 180‐day mortality. Conclusions AMI patients with hyperglycaemia on admission, independent of a history of diabetes, represent a high‐risk population for 180‐day mortality. The worst outcome occurs in non‐diabetic hyperglycaemic patients. Further studies are warranted to clarify the questions of hyperglycaemia treatment in AMI patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2005.01625.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 75

Metadata

Authors
Ainla, T., Baburin, A., Teesalu, R., & Rahu, M.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2005-09-13
Volume
22
Issue
10
Pages
1321-1325
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1976490895
Cited by
75
References
4
FWCI
3.10
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The association between hyperglycaemia on admission and 180‐day mortality in acute myocardial infarction patients with and without diabetes. https://app.cochat.ai/papers/10.1111/j.1464-5491.2005.01625.x
The paper
Ainla, T., Baburin, A., Teesalu, R., & Rahu, M. (2005). The association between hyperglycaemia on admission and 180‐day mortality in acute myocardial infarction patients with and without diabetes. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2005.01625.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.